Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Antenatal, general
  6. Antenatal Fetal Monitoring, Inpatients (641)
Announcements and latest updates

Right Decision Service newsletter: April 2024

Welcome to the Right Decision Service (RDS) newsletter for April 2024. 

Issues with RDS and Umbraco access

Tactuum has been working hard to address the issues experienced during the last week. They have identified a series of three mitigation measures and put the first of these in place on Friday 3rd May.  If this does not resolve the problems, the second mitigation will be actioned, and then the third if necessary.

Please keep a lookout for any slowing down of the system or getting locked out. Please email myself, mbuchner@tactuum.com and onivarova@tactuum.com if you experience any problems, and also please raise an urgent support ticket via the Support Portal.

Thank you for your patience and understanding while we achieve a full resolution.

Promotion and communication resources

A rotating carousel presenting some of the key RDS tools and capabilities, and an editable slideset, are now available in the Resources for RDS providers section of the Learning and Support toolkit.

Redesign and improvements to RDS

The redesign of RDS Search and Browse is still on-track for delivery by mid-June 2024. We then plan to have a 3-week user acceptance testing phase before release to live. All editors and toolkit owners on this mailing list will be invited to participate in the UAT.

The archiving and version control functionality is also progressing well and we will advise on timescales for user acceptance testing shortly.

Tactuum is also progressing with the deep linking to individual toolkits within the mobile RDS app. There are several unknowns around the time and effort required for this work, which will only become clear as the work progresses. So we need to be careful to protect budget for this purpose.

New feature requests

These have all been compiled and effort estimated. Once the redesign work is complete, these will be prioritised in line with the remaining budget. We expect this to take place around late June.

Evaluation

Many thanks to those of you completed the value and impact survey we distributed in February. Here are some key findings from the 65 responses we received.

Figure 1: Impact of RDS on direct delivery of care

Key figures

  • 93% say that RDS has improved evidence-informed practice (high impact 62%; some impact 31%)
  • 91% report that RDS has improved consistency in practice (high impact 65%, some impact 26%)
  • 85% say that RDS has improved patient safety (high impact 59%, some impact 26%)
  • Although shared decision-making tools are only a recent addition to RDS, and only represent a small proportion of the current toolset, 85% of respondents still said that RDS had delivered impact in this area (53% high impact, 32% some impact.) 92% anticipate that RDS will deliver impact on shared decision-making in future and 85% believe it will improve delivery of personalised care in future.

Figure 2 shows RDS impact to date on delivery of health and care services

 

Key figures

These data show how RDS is already contributing to NHS reform priorities and supporting delivery of more sustainable care.

Saving time and money

  • RDS clearly has a strong impact on saving practitioner time, with 90% of respondents reporting that this is the case. 65% say it has a high impact; 25% say it has some impact on time-saving.
  • It supports devolved decision-making across the multi-professional team (85% of respondents)
  • 76% of respondents confirm that it saves money compared, for example, to investing in commercial apps (54% high impact; 22% some impact.)
  • 72% believe it has impacted already on saving money and reducing waste in the way services are delivered – e.g. reducing costs of referral management, prescribing, admissions.

Quality assurance and governance

  • RDS leads are clear that RDS has improved local governance of guidelines, with 87% confirming that this is the case. (62% high impact; 25% some impact.)

Service innovation and workforce development

  • RDS is a major driver for service innovation and improvement (83% of respondents) and has impacted significantly on workforce knowledge and skills (92% of respondents – 66% high impact; 26% some impact).

New toolkits

A few examples of toolkits published to live in the last month:

Toolkits in development

Some of the toolkits the RDS team is currently working on:

  • SARCS (Sexual Assault Response Coordination Service)
  • Staffing method framework – Care Inspectorate.
  • SIGN 171 - Diabetes in pregnancy
  • SIGN 158 – British Guideline on Management of Asthma. Selected sections will be incorporated into the RDS, and complemented by a new chronic asthma pathway being developed by SIGN, British Thoracic Society and NICE.
  • Clinical pathways from NHS Fife and NHS Lanarkshire

Please contact his.decisionsupport@nhs.scot if you would like to learn more about a toolkit. The RDS team will put you in touch with the relevant toolkit lead.

Quality audit of RDS toolkits

Thanks to all of you who have responded to the retrospective quality audit survey and to the follow up questions.  We still have some following up to do, and to work with owners of a further 23 toolkits to complete responses. An interim report is being presented to the HIS Quality and Performance Committee.

Implementation projects

Eight clinical services and two public library services are undertaking tests of change to implement the Being a partner in my care app. This app aims to support patients and the public to become active participants in Realistic Medicine. It has a strong focus on personalised, person-centred care and a library of shared decision aids, as well as simple explanations and videoclips to help the public to understand the aims of Realistic Medicine.  The tests of change will inform guidance and an implementation model around wider adoption and spread of the app.

With kind regards

Right Decision Service team

Healthcare Improvement Scotland

Antenatal Fetal Monitoring, Inpatients (641)

Warning
Please report any inaccuracies or issues with this guideline using our online form

There is a recognised need for fetal monitoring for high risk patients whilst inpatients within the maternity unit. Although there is no clear evidence that antenatal cardiotocography improves perinatal outcome (Grivell et al, 2015) the main purpose of CTG recordings is to identify when there is concern about fetal well-being to enable interventions to be carried out before the fetus is harmed (Beckmann 2014).

The aim of this guideline is to provide a standardised approach to fetal monitoring within the inpatient setting for high risk patients.

All patients greater than 20 weeks gestation should have the fetal heart auscultated each day as a minimum as part of routine maternal observations. Where a patient is admitted to the antenatal ward, the admitting obstetrician must ensure a clear, defined plan stating the type and frequency of fetal monitoring is made and communicated to the midwifery staff.

Indications for antepartum cardiotocography

Some of the most common reasons for admission to the antenatal ward are highlighted below. Any plan for fetal monitoring may be directed by a medical plan of care.

Antepartum cardiotocography (CTG) should be considered in women of 26+0 gestation and above. CTG’s carried out before 28 weeks should be performed and interpreted with caution, the decision to do so must be made on an individual basis by a senior obstetrician. The fetal autonomic nervous system is not mature and therefore the patterns of fetal heart rate which may be expected at later gestations are not present. Also there is increased possibility of signal loss and poor quality CTG at earlier gestations (Afors and Chandraharan, 2011). All CTG traces should be peer reviewed by a trained team member. However, all normal CTG traces on fetuses below 32 weeks gestation should also be peer reviewed by an obstetrician during the shift.

If CTG is of poor quality there should be early recourse to ultrasound location of the fetal heart rate (ideally within 20 minutes).

Abdominal examination

A full abdominal examination should be carried out and documented prior to commencing a CTG trace. Ensure the woman has emptied her bladder and is comfortable. Measure fundal height in centimetres, palpate and document the findings. The fetal heart should be auscultated with a Pinard or doptone prior to commencement (Perinatal Institute 2018).

Cardiotocography interpretation

When reviewing the cardiotocograph (CTG) trace it is important to assess and document any contractions and all four features of fetal heart rate;

  • Baseline rate
  • Baseline variability
  • Presence or absence of decelerations
  • Presence of accelerations

It is also important to record maternal heart rate. Where there is any difficulty in categorising or interpreting a CTG trace, a review by a senior midwife or obstetrician should be obtained.

The RCOG Green-top Guideline on the management of reduced fetal movements recommends that interpretation of the antenatal CTG fetal heart rate pattern can be assisted by adopting the NICE classification of fetal heart rate features as indicated in their intrapartum care guideline. Therefore, as is the case when classifying intrapartum CTGs, it would seem reasonable to use a structured pro forma to ensure the use of consistent terminology. However, using an intrapartum pro forma is not appropriate as it acknowledges that some decelerations are acceptable in labour, which clearly cannot be the case for antenatal CTGs where there are no contractions.

Baseline rate (beats/minute) This is the average fetal heart rate within a ten minute window.

Baseline variability (beats/minute) This refers to the variation of fetal heart rate from one beat to the next. Variability occurs as a result of the interaction between the nervous system, chemoreceptors, baroreceptors and cardiac responsiveness.

Accelerations are an abrupt increase in the baseline fetal heart rate of greater than 15 bpm for greater than 15 seconds. The presence of fetal heart rate accelerations, even with reduced baseline variability, is generally a sign that the baby is healthy.

Decelerations are an abrupt decrease in the baseline fetal heart rate of greater than 15 bpm for greater than 15 seconds.

Any decelerations on an antenatal CTG should be considered abnormal and prompt medical review.

This pro forma has been adapted from PROMPT training and should be utilised for the classification of CTG traces in non-labouring women only.

Antenatal CTGReassuringNon-reassuring
Baseline rate (bpm)110-160 rate:Less than 109
More than 161
Sinusoidal pattern for 10 minutes or more
Variability5 bpm or moreLess than 5 bpm for more than 40 minutes
AccelerationPresentNone for 40 minutes
DecelerationsNoneUnprovoked deceleration/s
Decelerations related to uterine tightening (not in labour)
OpinionNormal CTG (all features reassuring)Abnormal CTG (1 or more non-reassuring features)

Antenatal CTG classification
Normal: A CTG where all four features fall into the ‘reassuring’ category.
Abnormal: A CTG with any non reassuring features (including any decelerations)

When an abnormal CTG is identified, it should be reviewed by an experienced obstetrician as soon as possible (within 30 minutes) to make a clear individualised action plan

Conservative measures

If there are any concerns about the baby’s wellbeing, be aware of the possible underlying causes and start one or more of the following conservative measures based on assessment of the most likely causes: encourage the woman to mobilise or adopt an alternative position ( and to avoid being supine); offer intravenous fluids if the woman is hypotensive or tachycardic.

All cardiotocograph traces must be peer reviewed prior to completion by either a member  of midwifery staff or an obstetrician and documented appropriately. If conservative measures fail to resolve an abnormal CTG trace, immediate review by an obstetrician should be sought and a clear and concise plan documented.

Preterm fetal monitoring

Antepartum cardiotocography should be considered in women of 26+0 weeks gestation and above. Any CTG carried out before 26 weeks should be performed and interpreted with caution. The decision to do so must be based on an individual basis by a consultant obstetrician.

Evidence suggests that the baseline fetal heart rate in preterm fetuses is at the higher end of the normal range for a term fetus for physiological reasons, but that this reverts to the range more consistent with term fetuses as gestation advances. However, any rate more than 160 bpm should be defined as tachycardia across all preterm gestational ages. The baseline variability may be reduced at preterm gestations for physiological reasons. However, at term, fetal heart rate variability is an important clinical indicator of fetal acid base balance and oxygenation of the autonomic nerve centres within the brain (NICE 2015).

Fetal heart rate decelerations are common and normal at very early preterm gestations (26 weeks and less) reflecting immature development of cardioregulatory mechanisms. The presence of shallow or short-lived decelerations in very preterm babies should not be considered necessarily as indicative of hypoxia when all other CTG features are reassuring.

From 32 weeks, baseline fetal heart rate and variability should be similar to that in term fetuses and accelerations with an amplitude of more than 15 beats from the baseline should be present as an indicator of fetal wellbeing. Decelerations can be interpreted as for the term fetus (NICE, 2015).

Antenatal ward fetal monitoring care plans

All care should be provided in conjunction with local guidelines and medical plan

There is little evidence regarding the timing and frequency of antenatal CTG monitoring within an inpatient setting. The following care plan has been devised from best practice within the antenatal ward setting.

A full antenatal examination should be carried out on admission to the ward including blood pressure, heart rate, oxygen saturations, temperature, respiratory rate, urinalysis and abdominal examination and fetal heart rate. A CTG trace should be carried out where indicated.

Antenatal fetal monitoring care plan table

Administration of intra muscular opiate analgesia on the antenatal ward

Opiate analgesia crosses the placenta acting as a vasoconstrictor of the placental vasculature. This may result in reduced fetal tone, reduced fetal movements and reduced- to-absent fetal breathing movements (Kopecky et al, 2000).

Although a CTG may not be indicated in low risk women, in order to ensure fetal wellbeing, CTG monitoring should be commenced prior to administration. On completion on a normal CTG trace, this should be discontinued then the fetal heart should then be auscultated and documented one hour post administration. It is important to remember that a cardiotocograph trace may then show non-reassuring or abnormal baseline variability following the administration of opiate analgesia and should be considered when interpreting the CTG.

Editorial Information

Last reviewed: 18/04/2019

Next review date: 01/04/2024

Author(s): Mandy Reid.

Approved By: Obstetrics Clinical Governance Group

Document Id: 641

References

Afors, K. and Chandraharan, E. (2011) Use of Continuous Electronic Fetal Monitoring in a Preterm Fetus: Clinical Dilemmas and Recommendations for Practice. Journal of Pregnancy Volume 2011, Article ID 848794. Available at https://www.hindawi.com/journals/jp/2011/848794/

Beckmann, M. (2014) National German Guideline: Guideline on the use of CTG During Pregnancy and Labour. Geburtsh Frauenheilk.

Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment (2015). Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD007863. DOI: 10.1002/14651858.CD007863.pub4.

Kopecky, E, Ryan, M, Barrett et al (2000) Fetal response to maternally administered morphine. American Journal of Obstetrics and Gynaecology. Vol 183-2, August 2000 Available at https://ac.els-cdn.com/S0002937800746710/1-s2.0S0002937800746710- main.pdf?_tid=77089bd4-3733-4276-9b11- f5216d79c2f0&acdnat=1521122523_2af4473790c63d9f12e65e3d59fd5cbe

National Institute for Health Care and Excellence (2017) Intrapartum Care (NICE Guideline CG190) Available at: https://www.nice.org.uk/guidance/cg190

National Institute for Health Care and Excellence (2015) Preterm Labour and Birth (NICE Guideline 25) Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0080792/pdf/PubMedHealth_PM H00 80792.pdf

Perinatal Institute (2018) Fetal Growth- Fundal Height Measurements. Available online at: https://www.perinatal.org.uk/FetalGrowth/FundalHeight.aspx